Announcements
- Certara Reports Fourth Quarter 2023 Financial Results
- Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
- Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
- Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
- Certara Reports Third Quarter 2023 Financial Results
- Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
- Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
- Certara to Participate in Upcoming Investor Conferences
- Certara Simcyp™ Group Awarded Two New Grants from US FDA
- Certara Reports Second Quarter 2023 Financial Results
More ▼
Key statistics
As of last trade, Certara Inc (700:HAM) traded at 16.10, 42.48% above the 52 week low of 11.30 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.10 |
---|---|
High | 16.10 |
Low | 16.10 |
Bid | 17.20 |
Offer | 17.60 |
Previous close | 15.70 |
Average volume | 0.00 |
---|---|
Shares outstanding | 159.86m |
Free float | 118.24m |
P/E (TTM) | -- |
Market cap | 2.82bn USD |
EPS (TTM) | -0.3478 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 07:10 BST.
More ▼